Skip to main content
Veterinary Medicines

Rossovet carnitina gocce Soluzione orale per cani e gatti

Not authorised
  • Cyanocobalamin
  • Levocarnitine
  • L-arginine hydrochloride
  • DL-methionine
  • L-ASPARTIC ACID
  • D-FRUCTOSE

Product identification

Medicine name:
Rossovet carnitina gocce Soluzione orale per cani e gatti
Active substance:
  • Cyanocobalamin
  • Levocarnitine
  • L-arginine hydrochloride
  • DL-methionine
  • L-ASPARTIC ACID
  • D-FRUCTOSE
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Cyanocobalamin
    0.10
    milligram(s)
    /
    1.00
    millilitre(s)
  • Levocarnitine
    82.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • L-arginine hydrochloride
    48.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • DL-methionine
    26.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • L-ASPARTIC ACID
    17.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • D-FRUCTOSE
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QV03AX
Authorisation status:
  • Surrendered
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Italia S.r.l
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
  • MdS
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 30/03/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."